PUNE: Molecules has expanded its global footprint by establishing a presence in Tokyo, aiming to accelerate global collaborative research programs involving academia, industry and technology partners in Japan, India and other key innovation hubs. The move marks a strategic milestone in the company’s efforts to build an integrated global research and innovation ecosystem, it said in a statement.Under the leadership of Dr. Sriraj Gopi, Molecules is focusing on developing structurally validated delivery platforms, particularly metasome-like liposomal and vesicular systems, to improve bioavailability, stability and functional outcomes.Japan’s advanced research infrastructure and precision-driven scientific ecosystem make it an ideal destination for scaling next-generation delivery technologies, the company said. The expansion is expected to accelerate collaborative research across institutions, enable joint development of advanced delivery systems including liposomal and neosomal technologies, and strengthen the scientific validation framework through advanced analytical capabilities.It will also support translational research aimed at turning scientific concepts into scalable, market-ready solutions, while promoting multidisciplinary knowledge exchange in areas such as nutraceuticals and functional foods.The company said the move reflects its broader vision to drive innovation through global collaboration and connect science with real-world applications.
